Clinical Trials Logo

Cross Infection clinical trials

View clinical trials related to Cross Infection.

Filter by:

NCT ID: NCT00791583 Completed - Clinical trials for Nosocomial Infections

ED Residents MBP During CVC Placement: Sim Lab Based Training

EM CVC MBP
Start date: May 2008
Phase: N/A
Study type: Observational

1. Baseline performance in maximal barrier precaution technique of Emergency Medicine (EM) residents, certified in CVC placement, is poor 2. Simulation-based training in maximal barrier precaution technique during central venous catheter (CVC) placement will improve baseline performance of EM residents

NCT ID: NCT00787345 Completed - Clinical trials for Nosocomial Infections

Simulation-based Training for Surgery Residents in Aseptic Techniques

CVC
Start date: May 2008
Phase: Phase 3
Study type: Interventional

Central line associated bloodstream infection (CL-ABI) is an important and preventable cause of nosocomial infections and is responsible for considerable morbidity and mortality The Centers for Disease Control have published guidelines for the prevention of CL-ABI that represent a collaborative effort by a multidisciplinary coalition of professional organizations that provide evidence based recommendations to prevent catheter related infections [5]. The interventions emphasize five distinct practices, including: education and training of healthcare providers who place and care for catheters, utilizing maximum sterile barrier precautions during catheter placement.

NCT ID: NCT00727363 Terminated - Death Clinical Trials

Prophylactic Probiotics in Premature Infants

C3P
Start date: August 2008
Phase: Phase 3
Study type: Interventional

This study tries to determine whether the oral administration of a specific probiotic (good bacteria) in premature infants hospitalized in a neonatal intensive care unit may prevent infections and the development of a severe inflammatory disease of the bowel called necrotizing enterocolitis. The investigators propose that premature infants not given probiotics will colonize their gut with bad bacterias and develop infection.

NCT ID: NCT00701948 Completed - Clinical trials for Nosocomial Infection

New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn

NOSODIAG
Start date: July 2008
Phase:
Study type: Observational

This study aims to evaluate new dosage of inflammatory markers or new inflammatory markers for the diagnosis of nosocomial bacterial infection. We made the hypothesis that these new dosages or new inflammatory markers could be more useful than dosage of inflammatory markers already used in clinical practice (especially the use of a combination of interleukins (6 or 8) and C-reactive protein for the management of newborns with a clinical suspicion of nosocomial bacterial infection and especially could allow to avoid excessive treatment with antibiotics

NCT ID: NCT00656708 Completed - Burns Clinical Trials

Kerlix Gauze Study in a Burn Trauma Unit and Its Effect on Healthcare Associated Infections in Burn Patients

Start date: August 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether Kerlix AMD gauze will decrease the incidence of healthcare associated infections in burn patients. Kerlix AMD gauze will be applied to all patients with open wounds admitted to the burn unit during the prospective portion of the study. All consenting patients will be assessed for hospital associated infections and outcomes. We hypothesis that burn patients will have a decreased number of hospital associated infections compared to historical controls.

NCT ID: NCT00645723 Recruiting - Clinical trials for Pneumonia, Bacterial

Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii

Start date: April 2008
Phase: Phase 3
Study type: Interventional

Compare the clinical efficiency evaluated by the treatment of the intravenous colistin plus inhaled colistin opposite to the treatment with colistin intravenous plus inhaled saline solution in patients with VAP due to baumannii carbapenems resistant.

NCT ID: NCT00617006 Completed - Clinical trials for Nosocomial Infections

Potential Nosocomial Infection Prevention Via Modification of Anesthesia Intraoperative Aseptic Practice

Start date: July 2007
Phase: N/A
Study type: Observational

We hypothesized that by improving hand hygiene compliance in the operative environment, we would reduce horizontal transmission of pathogenic bacteria to surgical patients.

NCT ID: NCT00563186 Completed - Clinical trials for Clostridium Difficile Infection

Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial

Start date: June 2007
Phase: N/A
Study type: Interventional

With the construction of a new medical teaching ward with features designed to reduce hospital-acquired infections, we hypothesized that the design of the new ward was the major factor that contributed to the improved outcomes and designed a prospective, controlled study to examine this hypothesis.

NCT ID: NCT00549393 Completed - Clinical trials for Nosocomial Infections

Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit

Start date: February 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators propose to conduct a large clinical study to determine if daily bathing with chlorhexidine impregnated cloths will reduce the incidence of healthcare-associated infections in the Pediatric Intensive Care Unit (PICU).

NCT ID: NCT00543894 Completed - Infection in ICU Clinical Trials

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients

ANTHICUS
Start date: February 2006
Phase: N/A
Study type: Observational

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients. A prospective, observational, multicenter study (ANTHICUS).